|
Market Closed -
Japan Exchange
02:30:00 2026-10-20 EDT
|
5-day change | 1st Jan Change | ||
| 6,430.00 JPY | +1.52% |
|
+4.21% | -21.99% |
| 09-22 | Chugai Pharma to Boost Capex by 50% to Expand In-House Production | MT |
| 08-21 | Alvotech Enters Licensing, Commercialization Deal for Two Biosimilars in US, Certain Asian Markets | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 65.79B | |||||
| 1,106B | |||||
| 612B | |||||
| 500B | |||||
| 367B | |||||
| 354B |
Select your edition
All financial news and data tailored to specific country editions
